Quick View
Loading...
Xeno Laboratories
Buy HMG 75 IU by Xeno Labs at XSteroids. This card carries a single 75 IU vial of menotropin, supplied as a powder that needs dissolving before use. The page sets out what the vial actually contains, how the two gonadotropin activities inside it work, what the research context looks like, the arithmetic of dissolving such a small dose, why it is usually discussed next to chorionic gonadotropin, what the safety notes and the sports rules say, and how the powder should be kept.
Menotropin is an approved prescription medicine used in fertility care, and the vial sold here is a different article. It is a research product without an approved dosing leaflet, without pharmacy registration and without any claim to replace a prescribed preparation. The active substance and the 75 IU unit of measurement are what the two have in common.
The vial holds 75 IU of human menopausal gonadotropin, a glycoprotein preparation originally extracted from the urine of postmenopausal women. Its defining feature is that it carries two activities at once: the classic ratio is 75 IU of follicle stimulating hormone together with 75 IU of luteinising hormone in the same vial, which is why it was historically labelled as a combined product.
Modern clinics have largely moved to recombinant gonadotropins that supply one clean activity instead of two, but the urinary preparation remains the reference format and the one the older literature describes. Strength is given in international units rather than milligrams because the substance is standardised by biological effect. As with any powder of this kind, there is no independent assay for this specific vial, so the page quotes the labelled figure and nothing beyond it.
The two activities inside the vial reach two different cell types in the testis. The follicle stimulating component binds receptors on the Sertoli cells, the support cells that govern sperm production, while the luteinising component binds the Leydig cells that manufacture testosterone. In women the same pair of signals drives follicular development and maturation, which is the basis of the approved fertility indication.
That combination is what separates it from chorionic gonadotropin, which mimics only the luteinising side and therefore stimulates testosterone production without doing anything directly for spermatogenesis. It also explains why fertility protocols dose menotropin daily or more frequently: neither activity persists long enough for a weekly schedule, and both are titrated against a monitored response rather than fixed in advance.
There is no dramatic physical signature. Body composition does not change, strength does not jump, and nothing about the experience resembles an anabolic cycle, because none of the activity is anabolic in itself. What is being tracked in a research setting is sperm parameters, hormone values and testicular response over weeks rather than days.
Hormone panels are where the change shows first. Because the luteinising component drives testosterone production in the Leydig cells, estradiol may drift upward with it, since the testosterone produced inside the testis aromatises like any other. Anyone reading a panel without that context can misread the second week of use as something going wrong.
Seventy-five international units is a very small quantity of powder, so the water volume decides everything. Dissolving one vial in 1 ml of bacteriostatic water gives 75 IU per ml, which means a single unit on a U-100 insulin syringe, one hundredth of a millilitre, carries 0.75 IU and ten units carry 7.5 IU. Using 1.5 ml instead gives 50 IU per ml, which is easier to draw but demands a larger injection volume for the same activity.
Because the numbers are small, the syringe matters as much as the arithmetic. An insulin syringe graduated in single units gives usable precision; a larger barrel does not. The approved fertility protocols use daily injections for around ten days under monitoring, and those schedules are repeated here only to explain where the 75 IU figure comes from.
The two gonadotropins are usually discussed as a set because they cover different cells. HCG 5000 IU supplies the luteinising signal and works on testosterone output, while this vial adds the follicle stimulating arm that reaches spermatogenesis. Neither is a complete substitute for the other, which is why a fertility conversation tends to name both before it names anything else.
The surrounding cycle decides how much support is needed. Testosterone Esters from Xeno Labs form the base in most plans, and the longer Nandrolone Esters suppress the axis more deeply, making recovery support a larger question. Where the base aromatises, Arimidex (anastrozole) belongs to the estradiol side of the plan.
In practice the vial appears at the end of long suppressive runs, when the concern is sperm production rather than muscle. The sequence usually runs through a gonadotropin phase first and a SERM phase afterwards, because gonadotropins do the work of the pituitary rather than restarting it, and the two mechanisms do not compound when taken together.
Tamox (tamoxifen) or Clomiphene carry the second half of that sequence, with blood work on both sides of it. Treating a research vial as a fertility treatment would be the wrong frame; the honest frame is that the substance has a documented medical use and this vial does not carry that approval.
Ovarian hyperstimulation is the headline warning for the approved fertility product, and it applies to the clinical context rather than to a research vial used elsewhere; it is nevertheless why monitoring exists around menotropin in medicine. In men the effects are hormonal rather than mechanical: a rise in testosterone production, a possible rise in estradiol, and the fluid shifts that follow estrogenic activity.
Injection site reactions, headache and mood change are reported with gonadotropin use. There is also a theoretical concern about infectious agents carried over from urine donors, which the literature treats as theoretical rather than demonstrated. Menotropin is named on the WADA prohibited list in class S2.2.1 and is banned for male athletes at all times. This page is a reference, not medical advice.
Unmixed, the vial is stable and wants refrigeration at 2 to 8 C with the light kept out. Once the powder is dissolved the clock starts: the solution goes into the refrigerator, stays between 2 and 8 C, is never frozen, and is used inside roughly four weeks. Any vial with a broken seal, a discoloured cake or visible particles after mixing is thrown away instead of injected.
Menotropin is carried in the Xeno Labs product range on this site, and the gonadotropin, base and SERM items that belong to the same research are stocked beside it, so a full sequence fits in a single order. Payment goes through an encrypted checkout and shipping stays discreet; a US destination is usually reached in three to six days, and international post needs twelve to twenty-six. The related cards below cover the products usually considered together with this one.
Seventy-five international units of menotropin, the human menopausal gonadotropin preparation. It carries both gonadotropin activities at once, classically 75 IU of follicle stimulating hormone and 75 IU of luteinising hormone in the same vial, which is the reason for the combined label.
Both descriptions apply to different things. Menotropin itself is an approved prescription medicine used in fertility treatment. The vial on this page is a lyophilised research product with no approved dosing leaflet and no pharmacy registration, so it is not the same article.
Because they act on different testicular cells. HCG mimics luteinising hormone and drives testosterone production in the Leydig cells. The follicle stimulating activity in menotropin reaches the Sertoli cells responsible for sperm production, which HCG does not do on its own.
It is a choice, not a fixed rule. One millilitre gives a concentration of 75 IU per ml, so ten units on a U-100 insulin syringe carry 7.5 IU. One and a half millilitres gives 50 IU per ml, which is easier to measure but needs more volume per dose.
Yes for men. Menotropin appears on the WADA prohibited list under class S2.2.1, testosterone stimulating peptides in males, alongside chorionic gonadotropin and luteinising hormone. The prohibition applies at all times, including outside the competition period, and women are not named by that class.
The approved fertility product carries warnings about ovarian hyperstimulation, multiple pregnancy and allergic reactions, which is why it is used under monitoring with ultrasound and hormone testing. None of those safeguards travel with a research vial, which is a difference worth stating plainly.
You can buy the HMG 75 IU vial by Xeno Labs online at XSteroids, direct from the brand catalogue. Add this page to the cart and complete the encrypted checkout. Domestic US parcels typically arrive in three to six days, and international shipments take twelve to twenty-six.
Loading...
Your cart is currently empty. Let us assist you in finding the right product